The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...

This story is from the next print edition of MIT Technology Review, which explores power—who has it, and who wants it. It’s ...

A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.

Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...

About 30% of all respiratory tract infections are caused by coronaviruses, leading to widespread illnesses and, in some cases, to epidemic and even pandemic outbreaks, as we experienced with the COVID ...

Augnition Labs, a neurotechnology company developing science-driven tools to advance cognitive health, today announced that ...

Rhythm Technologies, Inc.'s Q1 2025 growth, AI innovations, and market expansion. Click for why I upgraded IRTC to Buy ...

When two of medicine’s most outspoken reformers publish a roadmap for the FDA, you expect at least coherence. Instead, we get ...

Infinimmune published results in a new bioRxiv preprint, demonstrating that GLIMPSE-1 can humanize clinical antibodies, engineer for affinity and developability parameters, and generate highly ...

The protein language model is trained solely on paired human antibody sequences with scalable applications in antibody ...